Skip to content

Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney deficiency and cold coagulation

Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney deficiency and cold coagulation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042659
Enrollment
Unknown
Registered
2021-01-25
Start date
2021-01-25
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

Sponsors

The Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) It was in line with the diagnosis criteria of RA DAS28 > (2.6) of kidney deficiency and cold coagulation syndrome in Chinese medicine; (2) Aged 18-65 years, gender unlimited; (3) Those who voluntarily participate in the study and agree to sign the informed consent for entering the clinical study; (4) Doses were stable for at least 30 days before entry and remained constant for subsequent treatment in patients receiving NSAIDs and hormones. (5) Patients who voluntarily participate in the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Severe joint deformity joint function in patients with late ? level, above symptom severity classification of severe patients. (2) Patients with other rheumatic diseases, such as systemic lupus erythematosus, Sjogren's syndrome, severe knee osteoarthritis, etc. (3) patients with heart, brain, liver, kidney, hematopoietic system and other serious primary diseases. (4) Pregnant or lactating women, mental patients. (5) Participating in other drug clinical trials.

Design outcomes

Primary

MeasureTime frame
Therapeutic Effect of TCM Diseases;TCM syndrome score;DAS28 score;Joint swelling number;Number of joint tenderness;HAQ;VAS score for the degree of pain assessed by the patient;The patient assessed the overall condition of the disease VAS score;The overall condition VAS score for the disease was assessed by the researchers;ESR;CRP;RF parting;CCP;

Countries

China

Contacts

Public ContactXiaohu Tang

Yunnan Teaditional Chinese Medicine Hospital

h.tang0718@163.com+86 13064214246

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026